| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Memorial Sloan-Kettering Cancer Center, New York, New York 10021
In order to elucidate some of the factors that determine the characteristic expression of gangliosides in malignant melanoma and neuroblastoma the levels of ganglioside synthases (glycosyltransferases) were determined in a panel of cell lines from those tumors that exhibited a wide range of ganglioside composition. Sialyltransferases (GM3, GD3, GD1a, and GT1b synthases), N-acetylgalactosaminyltransferases (GM2 and GD2 synthases), and galactosyltransferase (GM1 and GD1b synthases) were analyzed in crude membrane preparations from these cells. The results confirmed the importance of GM3 and GD3 synthases in determining the prominence of the a (GM3 to GT1a) or b (GD3 to GQ1b) biosynthetic pathways. The overall ganglioside composition in cells was found to be dependent on the relative levels of specific enzymes acting sequentially or in competing pathways. In general, the pattern and levels of transferases correlated with the actual ganglioside content of the cell line, although several important discrepancies were noted. For example, in cell lines containing high amounts of GD2 ganglioside, the level of the preceding enzyme in the pathway (GD3 synthase) was unexpectedly low. Thus, the high GD2:GD3 ratios characteristic of most neuroblastomas result from low levels of GD3 synthase as well as high levels of GD2 synthase. In other cell lines, GD3 synthase was completely absent, resulting in the synthesis of GM2, but not GD2, by N-acetylgalactosaminyltransferase I, as would be expected. It was concluded that different glycosyltransferases play key roles in determining glycolipid expression in different cell types.
1 Supported by grants from the National Cancer Institute (CA08478 and CA21445).
2 To whom requests for reprints should be addressed, at Sloan-Kettering Institute, Section 6155, 1275 York Avenue, New York, NY 10021.
Received 4/30/92. Accepted 8/ 6/92.
This article has been cited by other articles:
![]() |
K. Swerts, B. De Moerloose, C. Dhooge, J. Vandesompele, C. Hoyoux, K. Beiske, Y. Benoit, G. Laureys, and J. Philippe Potential Application of ELAVL4 Real-Time Quantitative Reverse Transcription-PCR for Detection of Disseminated Neuroblastoma Cells Clin. Chem., March 1, 2006; 52(3): 438 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Wu, N. H. Segal, S. Sidobre, M. Kronenberg, and P. B. Chapman Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells J. Exp. Med., July 7, 2003; 198(1): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. B. Hoon, C. T. Kuo, S. Wen, H. Wang, L. Metelitsa, C. P. Reynolds, and R. C. Seeger Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow Am. J. Pathol., August 1, 2001; 159(2): 493 - 500. [Abstract] [Full Text] |
||||
![]() |
J. Li, D. M. Rancour, M. L. Allende, C. A. Worth, D. S. Darling, J. B. Gilbert, A. K. Menon, and W. W. Young Jr. The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding Glycobiology, March 1, 2001; 11(3): 217 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fukumoto, H. Miyazaki, G. Goto, T. Urano, K. Furukawa, and K. Furukawa Expression Cloning of Mouse cDNA of CMP-NeuAc:Lactosylceramide alpha 2,3-Sialyltransferase, an Enzyme That Initiates the Synthesis of Gangliosides J. Biol. Chem., April 2, 1999; 274(14): 9271 - 9276. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyazaki, S. Fukumoto, M. Okada, T. Hasegawa, K. Furukawa, and K. Furukawa Expression Cloning of Rat cDNA Encoding UDP-galactose:GD2 beta 1,3-galactosyltransferase That Determines the Expression of GD1b/GM1/GA1 J. Biol. Chem., October 3, 1997; 272(40): 24794 - 24799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Furukawa, H. Soejima, N. Niikawa, H. Shiku, and K. Furukawa Genomic Organization and Chromosomal Assignment of the Human beta 1,4-N-Acetylgalactosaminyltransferase Gene. IDENTIFICATION OF MULTIPLE TRANSCRIPTION UNITS J. Biol. Chem., August 23, 1996; 271(34): 20836 - 20844. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamashiro, M. Haraguchi, K. Furukawa, K. Takamiya, A. Yamamoto, Y. Nagata, K. O. Lloyd, H. Shiku, and K. Furukawa Substrate Specificity of beta1,4-N-Acetylgalactosaminyltransferase in Vitro and in cDNA-transfected Cells J. Biol. Chem., March 17, 1995; 270(11): 6149 - 6155. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |